SELECT * FROM program_table WHERE parent_id IS NULL
Our Products
Generic Name
g1 sdsadsa

Therapeutic area
Herbal Medicine

Dosage Form
d1 sdsadsad

Usage
u1 sdsadsadsa
Generic Name
g 2_1

Therapeutic area
Food Supplement

Dosage Form
d 2_1

Usage
u 2_1
Generic Name
g 2_2

Therapeutic area
Food Supplement

Dosage Form
d 2_2

Usage
u 2_2
Generic Name
g 3_1

Therapeutic area
Alimintary & Metabolism

Dosage Form
d 3_1

Usage
u 3_1
Generic Name
g 3_2

Therapeutic area
Alimintary & Metabolism

Dosage Form
d 3_2

Usage
u 3_2
Generic Name
g 3_3

Therapeutic area
Alimintary & Metabolism

Dosage Form
d 3_3

Usage
u 3_3
Generic Name
g4

Therapeutic area
Blood & Blood Forming Organs

Dosage Form
d4

Usage
u4
Generic Name
g5

Therapeutic area
Cardiovascular

Dosage Form
d5

Usage
u5
Generic Name
g6

Therapeutic area
Dermatologicals

Dosage Form
d6

Usage
u6
Generic Name
g7

Therapeutic area
Genital-urinary systems & Sex Hormones

Dosage Form
d7

Usage
u7
Generic Name
g8

Therapeutic area
Herbal Medicine

Dosage Form
d8

Usage
u8
Generic Name
g9

Therapeutic area
Herbal Medicine

Dosage Form
d9

Usage
u9
Generic Name
g10

Therapeutic area
Antineoplast & Immunomodulators

Dosage Form
d10

Usage
u10
Generic Name
g11

Therapeutic area
Muscu-skeletal system

Dosage Form
d11

Usage
u11
Generic Name
g12

Therapeutic area
Nervous system

Dosage Form
d12

Usage
u 12
Generic Name
g13

Therapeutic area
Parasitology

Dosage Form
d13

Usage
u13
Generic Name
g14

Therapeutic area
Herbal Medicine

Dosage Form
d14

Usage
u14
Generic Name
g15

Therapeutic area
Herbal Medicine

Dosage Form
d15

Usage
u15
Generic Name
g 16_1

Therapeutic area
Herbal Medicine

Dosage Form
d 16_1

Usage
u 16_1
How drugs are made?
Pharmaceutical products are made through complex processes involving research, development, manufacturing, and quality control. Here's a simplified overview


1. Research and Development (R&D)

We identify potential drug candidates through research, often targeting specific diseases or conditions. This stage involves testing compounds in laboratories and studies to assess efficacy and safety.

Marcyrl Research and development (R&D) is the key driver in developing and introducing new products to national & international markets improving the population’s overall health and economic situation by reducing hospitalizations and operating costs in the healthcare sector through:
Let’s work together
Export Capabilites
Marcyrl Pharmaceutical Industries, an Egyptian pharmaceutical manufacturer, has secured investment from Development Partners International (DPI) and Amethis. They focus on specialty generics, to improve access to critical care drugs across Africa. Marcyrl’s growth includes expanding its product portfolio and addressing the demand for affordable specialty generics in Africa. The investment underscores the significance of the pharmaceutical sector and Marcyrl’s commitment to bridging healthcare gaps in the continent.

Capitalizing on our EU-approved GMP sites, Marcyrl Pharmaceutical Industries is exporting a wide range portfolio of medicines to 23 export markets including GCC, LEVANT, and AFRICA

Our ambitious plan to expand our export business in Africa, CIS, GCC, and LATAM.